CCI has a diverse portfolio of innovative technologies and Spin-off companies focused on bringing Clinic technology to market.
The portfolio of Spin-offs include device, diagnostic, biopharma and healthcare IT companies from concept stage through IPO. To date, 9 Cleveland Clinic spin-offs have been monetized.
In addition to our Spin-offs, CCI’s rich portfolio of Cleveland Clinic technologies span the entire continuum of care and all medical arenas. Health Information Technology is our fastest growing segment, and continues to make great strides in making care more efficient. If interested in investing or licensing, please contact our team who can walk you through all options available.
Tolera Therapeutics, Inc. develops antibodies and therapies that will prepare patients for an upcoming transplant, thus reducing the chances for rejection.
Talis Clinical commercializes an Anesthesia information management system that has been used in Cleveland Clinic operating rooms since 2010
Jeff specializes in technology selection in the context of creation, development and growth of new ventures. Leveraging extensive transactional experience in the capital markets, Jeff also focuses on capitalization and financing strategies for CCI spin-offs. Prior to joining CCI he spent time with a number of boutique investment banks helping pre-commercial stage public and private life science and healthcare companies secure investment capital. He holds a BS in Biochemistry and Molecular Biology from Marquette University and a PhD in Biochemical Pharmacology from the University of Cincinnati College of Medicine.
Learn about upcoming education events.
Innovations has facilitated several Cleveland Clinic Spin-Offs over the last decade. Click here to see our current portfolio.
Cleveland Clinic © 2014